17.12.2010,
in
Soci 2010
Cerbios’ HPAI manufacturing facility P5 meets control performance within SafeBridge’s® Category 4
Last summer, Cerbios-Pharma SA (from now on “Cerbios”) commissioned SafeBridge Europe, Ltd. (from now on “SafeBridge”) to carry out a surrogate containment performance assessment of three isolators located in P5 manufacturing unit at Cerbios site located in Lugano, Switzerland.
25.11.2010,
in
Soci 2010
Cerbios obtains Air Cargo Security Known Consignor Certification/2009
Cerbios-Pharma SA (from now on “Cerbios”) is proud to confirm that the UFAC (Swiss Authority of Aviation) has granted the Air Cargo Security Known Consignor Certification (from now on “Certification”) to Cerbios.
08.11.2010,
in
Soci 2010
Helsinn continua il suo impegno a contribuire al progresso della ricerca medico-scientifico sul territorio ticinese
Contributo per l'Istituto Oncologico della Svizzera Italiana (IOSI)
01.10.2010,
in
Soci 2010
Cerbios Pharma successfully passes a general GMP inspection
Cerbios-Pharma SA
24.09.2010,
in
Soci 2010
APR Applied Pharma Research SA - LABORATORIOS CINFA
LABORATORIOS CINFA launches Respirub in Spain, an innovative formulation of a balsamic rub cream, also available in pediatric formulation, developed by APR Applied Pharma Research.
23.09.2010,
in
Soci 2010
mondoBIOTECH holding AG (SIX:RARE): Presenting at the Biotech in Europe Investor Forum in Zurich
Mondobiotech SA
15.09.2010,
in
Soci 2010
APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study
APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study on Zolmitriptan RapidFilm®, and its upcoming submission for registration in Europe.
14.09.2010,
in
Soci 2010
